海普瑞藥業 Hepalink Pharmaceutical
深圳市海普瑞藥業股份有限公司是全球最大的肝素鈉原料藥供應商,公司產品出口全球,客戶包括世界知名的跨國醫藥企業,如Sanofi-Aventis,Fresenius Kabi,Novartis等。
海普瑞于1998年成立,2007年改制為股份有限公司,2010年5月6日在深交所掛牌上市,證券簡稱“海普瑞”,證券代碼為“002399”。公司注冊資本80,020萬元,總部位于環境優美的深圳市高新技術園,擁有八家子公司。
多年來,海普瑞在肝素納產品研發生產的專業領域精耕細作,獨創了世界領先的肝素鈉“雜質與組合分離技術”、“基團完整性保護和活性釋放技術”等核心工藝技術體系, 建立了符合我國藥品GMP規范以及美國和歐盟cGMP藥品規范和理念的全面質量管理體系,公司不僅順利通過了美國FDA及歐盟CEP的藥政批準,還是美國藥典標準修訂的主要參與者和標準提供者。
海普瑞還先后承擔了國家生物高技術產業化示范工程項目、國家火炬計劃項目、國家重點技術創新項目等國家級科技項目,為我國肝素產業的技術進步、產業升級、出口創匯能力的提高做出了重要貢獻, 公司先后取得“國家技術創新優秀新產品獎 ”、“深圳經濟特區30年杰出貢獻企業”、“深圳市優秀民營企業”、“深圳市優強中小企業”、“深圳市民營領軍骨干企業”等榮譽,成為國家和深圳市的重點高新技術企業。
Shenzhen Hepalink Pharmaceutical Co., Ltd (Hepalink) is the largest supplier of Heparin Sodium API in the world, distributing its products in the global markets and internationally renowned pharmaceutical companies, e.g. Sanofi-Aventis, Fresenius Kabi, and Novartis.
Hepalink was established in 1998 and restructured in 2007 to be a limited liability company. Hepalink went public and was listed on the Shenzhen Stock Exchange on May 6, 2010 (stock code "002399"). Hepalink headquarters are located in the Shenzhen High-Tech Park.
Hepalink has created a proprietary process for dealing with impurities and composition separation and activity release technologies. Hepalink has established a comprehensive quality management system in line with China GMP standards and the US and European cGMP standards and regulations. Hepalink is approved by the U.S. FDA and EU regulatory authorities, and it is also one of the primary participants in the revision of the USP pharmacopeia standards.
Hepalink also has successfully undertaken National Science and Technology Projects, such as National Bio-tech Industrialization Demonstration Project, National Torch Project, and National Key Technology Innovation Project. Through these projects, Hepalink has made a significant contribution to the technological progress of China's Heparin industry, and export capabilities.
Hepalink, as a leading high-tech enterprise has received numerous awards, including the National Award for Technology Innovation and Outstanding New Products, Enterprise with Outstanding Contribution for the Past 30 Years in the Shenzhen Special Economic Zone, Shenzhen Excellent Private Enterprise, Shenzhen Excellent and Strong SME, and Shenzhen Leading Private Enterprise.